Tetra Bio-Pharma buys PPP, increases control of CBD drug development
Ottawa Ontario-based Tetra Bio-Pharma Inc. (TSX VENTURE:TBP) (OTC:TBPMF), a cannabinoid-based drug development company, announced a share purchase agreement of assets controlled by André Rancourt, Chairman of the Board, and Guy Chamberland, Chief Scientific Officer.
Tetra will buy all of the common shares held by Rancourt and Chamberland of Tetra’s subsidiary, Phytopain Pharma for $12.4 million. This is 20% of the Phytopain Pharma.
PPP will become a wholly-owned subsidiary of Tetra.
“This transaction will be a significant milestone for Tetra Bio-Pharma and all our stakeholders,” said Bernard Fortier, Tetra’s CEO.
“The two selling shareholders … are both committed to the long-term success of Tetra as evidenced by their agreement to accept shares in Tetra in lieu of an all- cash transaction.
Tetra will gain 100% control of Phytopain Pharma, a key asset in the development of their pipeline of cannabinoid-based drugs.
The Transaction is subject to customary closing conditions.
Tetra Bio-Pharma buys PPP, increases control of CBD drug development
About Cannin Investment Group: Your Pot Stocks Experts
Cannin is your trusted resource for pot stocks. Our global team of experts evaluates all emerging pot stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best pot stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in pot stocks? No! This is the perfect time to invest.
Market analysts expect the legal cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in pot stocks is now. Are you looking to buy stock in pot companies for 2020? Interested in emerging penny pot stocks? Looking for the best Canadian pot stocks to invest in? We can help.
Are you interested in pot stocks like Curaleaf, Trulieve, Aurora Cannabis, or Canopy Growth?
Predict price movements of pot stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading pot stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best pot stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Buy
